home / stock / hbp / hbp news

HBP News and Press, Huttig Building Products Inc.

Stock Information
Company Name: Huttig Building Products Inc.
Stock Symbol: HBP
Market: NASDAQ
Website: huttig.com
Menu
HBP HBP Quote HBP Short HBP News HBP Articles HBP Message Board
Get HBP Alerts

News, Short Squeeze, Breakout and More Instantly...
HBP - Helix BioPharma Corp. Announces Fiscal 2024 First Quarter Results

--News Direct-- Toronto, Ontario – TheNewswire – December 14, 2023 – Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based o...
HBP - Helix Biopharma Corp. Announces Fiscal 2023 Year-End Results

(TheNewswire) Toronto, Ontario - TheNewswire - October 27, 2023 - Helix BioPharma Corp. (TSX:HBP) , (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immu...

HBP - Helix Biopharma Announces Upcoming Poster Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

--News Direct-- Toronto, Ontario - TheNewswire - October 10, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), an immune-oncology antibody-drug-conjugate company developing an innovative drug platform for the treatment of cancer, announced today th...

HBP - Helix BioPharma Corp. Announces Closing of Private Placement of CAD $3 Million and Board Changes

(TheNewswire) Toronto, Ontario - TheNewswire - August 22, 2023 - Helix BioPharma Corp. (TSX:HBP) (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology...
HBP - Helix BioPharma Corp. Announces Fiscal 2023 Third Quarter Results

--News Direct-- Toronto, Ontario – TheNewswire – June 14, 2023 - Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its propr...

HBP - Helix Biopharma Corp. Announces Fiscal 2023 Second Quarter Results

--News Direct-- Toronto, ON - TheNewswire - March 15, 2023 - Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technologic...

HBP - Helix Biopharma Corp. Reports Voting Results

--News Direct-- Toronto, Ontario – TheNewswire – January 24, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its propri...
HBP - Helix Biopharma Corp. Announces Grant & Cancellation of Stock Options

--News Direct-- Toronto, ON - TheNewswire - January 9, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological ...

HBP - Helix BioPharma Corp. Announces Fiscal 2023 First Quarter Results

--News Direct-- Toronto, Ontario – Thenewswire – December 14, 2022 – Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based o...

HBP - Helix Biopharma Corp. Announces Board & Management Changes

--News Direct-- Toronto, ON – TheNewswire -  December 8, 2022 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its propriet...
Next 10